DLL1 and neoplasm: To determine if the Dll1+ tumor cells resemble TICs that could increase tumor burden, metastasis, and chemotherapeutic resistance, the transcriptional signatures of Dll1+ and Dll1− tumor cells were further evaluated by RNA-seq analysis.